COVID-19 diaries: To boost or not to boost?
As we emerge from a horrible winter of COVID-19, influenza and other respiratory viruses, the COVID-19 vaccine landscape is as complex as ever.
Eligibility for the fourth COVID-19 vaccine dose was expanded by ATAGI in July to include a recommendation for those aged 50-64 years to receive it while 30-49-year-olds were made eligible to receive it but not outright recommended to do so.1